Prognosis of Acute Symptomatic Seizures in Neurosurgery

Recruiting

• Conditions: G40.5; Special epileptic syndromes

• Registration Number: DRKS00032119
• Lead Sponsor: Charité - Universitätsmedizin Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Acute symptomatic, first-ever epileptic eizure due to traumatic brain injury, subdural haematoma, or intracranial surgery

Exclusion Criteria

Status epilepticus

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence and time point of a first unprovoked epileptic seizure relapse within 12 months of the acute symptomatic first-ever seizure.

Secondary Outcome Measures

Name	Time	Method
Occurrence and time point of a first unprovoked epileptic seizure relapse within 5 years of the acute symptomatic first-ever seizure; occurrence and time point of additional acute symptomatic seizures; use of anti-seizure medication; seizure-related rehospitalisation; overall functional outcome (Glasgow Outcome Score Extended); EEG findings.